DMAC (DMAC) Stock Price & Analysis
DMAC (DMAC) rose 2.90% to USD 6.75 as of September 8, 2026 at 09:04 UTC, according to Nexqual real-time market data.
DMAC last closed at USD 6.75; the session ranged USD 6.49–6.89 on volume of 189,481 shares. Market capitalization is —, with a 52-week range of USD 5.25–10.42 (NCM). Source: Nexqual, September 8, 2026 at 09:04 UTC.
Key Statistics (as of September 8, 2026 at 09:04 UTC)
| Price | USD 6.75 |
|---|---|
| Change | ▲ 2.90% (up) |
| Previous Close | USD 6.75 |
| Open | USD 6.75 |
| Day Range | USD 6.49 – 6.89 |
| 52-Week Range | USD 5.25 – 10.42 |
| Volume | 189,481 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (DMAC)
Nexqual's technical model rates DMAC "NEUTRAL" based on 3 bullish and 2 bearish signals across 128 daily candles, as of September 8, 2026 at 09:04 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 50.69 (neutral) |
| vs SMA50 | Below (USD 6.91) |
| MACD | -0.04 (negative) |
From DMAC's Latest SEC 10-K Filing (filed 2026-03-30)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| COCP | Cocrystal Pharma, Inc. | USD 1.13 | ▼ 2.59% |
| ETON | Eton Pharmaceuticals, Inc. | USD 58.45 | ▼ 5.66% |
| TRVI | Trevi Therapeutics, Inc. | USD 17.26 | ▲ 1.23% |
| CYCN | Cyclerion Therapeutics, Inc. | USD 4.25 | ▲ 0% |
| FENC | Fennec Pharmaceuticals Inc. | USD 12.39 | ▲ 0.65% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 09:04 UTC. This page is informational and not investment advice.